Vident Investment Advisory’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-42,430
Closed -$2.34M – 807
2019
Q4
$2.34M Buy
+42,430
New +$2.3M 0.15% 209
2019
Q2
– Sell
-48,705
Closed -$2.26M – 507
2019
Q1
$2.26M Sell
48,705
-1,531
-3% -$77.6K 0.12% 259
2018
Q4
$2.47M Sell
50,236
-6,595
-12% -$375K 0.14% 176
2018
Q3
$3.52M Sell
56,831
-16,810
-23% -$1.02M 0.14% 167
2018
Q2
$3.97M Buy
73,641
+13,399
+22% +$670K 0.16% 122
2018
Q1
$2.76M Buy
+60,242
New +$2.58M 0.11% 261
2017
Q4
– Sell
-29,180
Closed -$1.08M – 796
2017
Q3
$1.08M Buy
+29,180
New +$1.04M 0.06% 356
2015
Q4
– Sell
-13,729
Closed -$419K – 510
2015
Q3
$419K Buy
13,729
+1,755
+15% +$61.1K 0.06% 598
2015
Q2
$439K Buy
11,974
+684
+6% +$24.4K 0.06% 583
2015
Q1
$398K Buy
11,290
+924
+9% +$31.6K 0.08% 548
2014
Q4
$317K Buy
+10,366
New +$323K 0.11% 446

Other funds holding EHC

Vident Investment Advisory's EHC Position: Q1 2020 in Review

Vident Investment Advisory sold out of Encompass Health (EHC) in Q1 2020, closing a stake of 42,430 shares — an estimated $2.34M sold.

Vident Investment Advisory first reported a position in EHC in Q4 2014 and held it in 11 quarters. The position peaked at $3.97M in Q2 2018. 374 funds tracked by Wall St. Rank hold EHC as of Q1 2020.

  • Vident Investment Advisory reported no remaining Encompass Health position as of Q1 2020 after selling out during the quarter.
  • Vident Investment Advisory sold 42,430 Encompass Health shares in Q1 2020, an estimated $2.34M.
  • Vident Investment Advisory first reported a position in Encompass Health in Q4 2014 and held it in 11 quarters.
  • Vident Investment Advisory's Encompass Health position peaked at $3.97M in Q2 2018.
  • 374 funds tracked by Wall St. Rank held Encompass Health as of Q1 2020.

Based on Vident Investment Advisory's 13F filing for Q1 2020, filed 12 May 2020.